A Phase I trial assessing the pharmacokinetics and tolerability of ZD1839 ('Iressa') in hepatically impaired patients with solid tumours

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Harris A, Twelves C, White J, Verrill M, Carmichael J, Farebrother J, Smith R, Laight A

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: European Journal of Cancer: 14th EORTC/NCI/AACR Symposium on Molecular Targets and Cancer Therapeutics

Year of Conference: 2002

Pages: S55-S56 abstract no. 174

ISSN: 0959-8049

Publisher: Pergamon

Library holdings: Search Newcastle University Library for this item

ISBN: 18790852

ePrints